CYLD and melanoma: A recent report proposed that the loss of CYLD in melanoma cells leads to the upregulation of euchromatic histone-lysine N-methyltransferase 2 (EHMT2), which is associated with the di-methylation of H3K9 and heterochromatin formation and contributes to increased tumor proliferation [62].